创新医疗
(002173)
| 流通市值：35.92亿 | | | 总市值：38.13亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 547,164,141.38 | 555,534,972.1 | 543,823,060.69 | 563,083,485.71 |
| 应收票据及应收账款 | 111,110,613.96 | 124,121,064.22 | 123,869,681.86 | 102,840,031.95 |
| 应收账款 | 111,110,613.96 | 124,121,064.22 | 123,869,681.86 | 102,840,031.95 |
| 预付款项 | 3,359,624.47 | 2,700,535.54 | 3,678,319.44 | 2,600,012.09 |
| 其他应收款合计 | 2,459,106.47 | 2,030,728.66 | 1,770,526.33 | 1,531,958.32 |
| 存货 | 38,960,002.85 | 36,111,389.88 | 37,726,419.22 | 41,805,047.04 |
| 其他流动资产 | 1,396,479.65 | 1,324,321.27 | 1,954,498.63 | 1,122,638.28 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 717,701,375.28 | 732,609,697.47 | 733,496,501.97 | 733,059,385.69 |
| 非流动资产: | | | | |
| 长期股权投资 | 13,101,441.86 | 13,886,733.09 | 14,345,628.32 | 15,219,218.88 |
| 固定资产 | 1,259,849,268.92 | 1,277,734,263.3 | 1,292,246,152.33 | 1,310,116,701.82 |
| 在建工程 | 3,745,623.56 | 2,401,570.15 | 6,613,671.99 | 5,945,341.99 |
| 使用权资产 | 26,668,744.49 | 29,027,952.17 | 31,719,776.92 | 33,752,293.3 |
| 无形资产 | 129,505,154.05 | 130,932,445.55 | 132,548,741.03 | 129,557,828.85 |
| 商誉 | 986,746.86 | 986,746.86 | 986,746.86 | 986,746.86 |
| 长期待摊费用 | 34,712,750.31 | 35,626,249.14 | 33,148,622.33 | 34,046,218.38 |
| 递延所得税资产 | 19,577,031.11 | 17,460,487.09 | 17,399,056.11 | 17,009,565.54 |
| 其他非流动资产 | 14,148,327.62 | 2,080,502.97 | 1,779,471.22 | 1,779,471.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,502,295,088.78 | 1,510,136,950.32 | 1,530,787,867.11 | 1,548,413,386.84 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,219,996,464.06 | 2,242,746,647.79 | 2,264,284,369.08 | 2,281,472,772.53 |
| 流动负债: | | | | |
| 短期借款 | 41,051,332.73 | 43,000,000 | 43,170,500 | 30,170,500 |
| 应付票据及应付账款 | 191,933,745.75 | 198,531,366.77 | 201,966,108.62 | 208,122,774.97 |
| 应付账款 | 191,933,745.75 | 198,531,366.77 | 201,966,108.62 | 208,122,774.97 |
| 预收款项 | 38,357.94 | 38,333.34 | 103,333.34 | 47,191.64 |
| 合同负债 | 3,134,146.92 | 3,792,270.65 | 3,558,620.35 | 3,521,976.69 |
| 应付职工薪酬 | 33,952,172.63 | 31,819,783.29 | 31,415,084.1 | 46,033,213.11 |
| 应交税费 | 6,967,926.12 | 5,341,616.66 | 2,496,069.65 | 6,573,408.57 |
| 其他应付款合计 | 13,601,991.82 | 14,783,101.49 | 13,791,909.94 | 12,911,543.12 |
| 一年内到期的非流动负债 | 15,832,231.32 | 15,898,349.22 | 17,181,168.06 | 18,046,198.2 |
| 其他流动负债 | - | - | 532.08 | 532.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 306,511,905.23 | 313,204,821.42 | 313,683,326.14 | 325,427,338.38 |
| 非流动负债: | | | | |
| 长期借款 | 8,000,000 | 8,000,000 | - | - |
| 租赁负债 | 13,744,414.1 | 16,250,913.44 | 17,743,854.31 | 20,326,780.92 |
| 预计负债 | 445,814.13 | 1,934,561.07 | 16,219,933.8 | 15,976,526.18 |
| 递延收益 | 3,702,699.42 | 3,858,058.59 | 4,013,417.76 | 4,168,776.93 |
| 递延所得税负债 | 44,201,376.76 | 44,296,329.82 | 44,516,282.88 | 44,486,235.94 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 70,094,304.41 | 74,339,862.92 | 82,493,488.75 | 84,958,319.97 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 376,606,209.64 | 387,544,684.34 | 396,176,814.89 | 410,385,658.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 441,284,352 | 441,284,352 | 449,043,052 | 449,043,052 |
| 资本公积 | 2,708,003,168.7 | 2,708,003,168.7 | 2,748,648,181.3 | 2,748,648,181.3 |
| 减:库存股 | - | - | 48,403,712.6 | 48,403,712.6 |
| 盈余公积 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 |
| 未分配利润 | -1,332,081,858.74 | -1,320,267,304.76 | -1,307,215,574.97 | -1,304,237,711.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,842,307,968.32 | 1,854,122,522.3 | 1,867,174,252.09 | 1,870,152,115.48 |
| 少数股东权益 | 1,082,286.1 | 1,079,441.15 | 933,302.1 | 934,998.7 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,843,390,254.42 | 1,855,201,963.45 | 1,868,107,554.19 | 1,871,087,114.18 |
| 负债和股东权益合计 | 2,219,996,464.06 | 2,242,746,647.79 | 2,264,284,369.08 | 2,281,472,772.53 |
| 公告日期 | 2024-10-25 | 2024-08-10 | 2024-04-27 | 2024-04-13 |
| 审计意见(境内) | | | | 标准无保留意见 |